Businesses operating in the medicinal cannabis sector are welcoming the government’s move to proceed with a referendum at the next election on whether it should legalise and regulate cannabis.
Helius Therapeutics executive director Paul Manning says while the company is focused solely on the
Want to read more? It's easy.
Choose your best value subscription option
Student
Exclusive offer for uni students studying at a New Zealand university (valued at $499).
